APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Nausea and Vomiting Healthcare Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Nausea and Vomiting Healthcare Device Industry Growth and Trends Forecast to 2032

29 December 2025109 pages

Choose your research edition.

Industry ResearchAnti-Nausea and Vomiting Healthcare Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Nausea and Vomiting Healthcare Device Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Anti-Nausea and Vomiting Healthcare Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Nausea and Vomiting Healthcare Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Nausea and Vomiting Healthcare Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anti-Nausea and Vomiting Healthcare Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Nausea and Vomiting Healthcare Device include Blisslets, Dramamine(Prestige Consumer Healthcare), EmeTerm (WAT Medical), GRAVOL, MotionCure (Sidis Labs), NoMo, Psi Bands, Quease EASE (Soothing Scents) and Reliefband, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Nausea and Vomiting Healthcare Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Nausea and Vomiting Healthcare Device market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Nausea and Vomiting Healthcare Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Nausea and Vomiting Healthcare Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Nausea and Vomiting Healthcare Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Nausea and Vomiting Healthcare Device Market by Company

Blisslets

Dramamine(Prestige Consumer Healthcare)

EmeTerm (WAT Medical)

GRAVOL

MotionCure (Sidis Labs)

NoMo

Psi Bands

Quease EASE (Soothing Scents)

Reliefband

Sea-Bands

Toulifly

Walgreens

Anti-Nausea and Vomiting Healthcare Device Segment by Type

Inhaler

Wrist Band

Food

Others

Anti-Nausea and Vomiting Healthcare Device Segment by Application

For Children

For Pregnant

For other people with motion sickness

Anti-Nausea and Vomiting Healthcare Device Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Nausea and Vomiting Healthcare Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Nausea and Vomiting Healthcare Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Nausea and Vomiting Healthcare Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Nausea and Vomiting Healthcare Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Nausea and Vomiting Healthcare Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inhaler Table 2. Major Company of Wrist Band Table 3. Major Company of Food Table 4. Major Company of Others Table 5. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 7. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type (2021-2026) Table 8. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 9. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type (2021-2026) Table 10. Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2026) & (US$/Unit) Table 11. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 12. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type (2027-2032) Table 13. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (US$ Million) Table 14. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type (2027-2032) Table 15. Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2027-2032) & (US$/Unit) Table 16. North America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 17. North America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 19. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 23. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (US$ Million) Table 26. Anti-Nausea and Vomiting Healthcare Device Industry Trends Table 27. Anti-Nausea and Vomiting Healthcare Device Industry Drivers Table 28. Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges Table 29. Anti-Nausea and Vomiting Healthcare Device Industry Restraints Table 30. Global Anti-Nausea and Vomiting Healthcare Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Company (2021-2026) Table 32. Global Anti-Nausea and Vomiting Healthcare Device Sales by Company (2021-2026) & (K Units) Table 33. Global Anti-Nausea and Vomiting Healthcare Device Sales Share by Company (2021-2026) Table 34. Global Anti-Nausea and Vomiting Healthcare Device Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Anti-Nausea and Vomiting Healthcare Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Anti-Nausea and Vomiting Healthcare Device Major Company Production Sites and Headquarters Table 37. Global Anti-Nausea and Vomiting Healthcare Device Company, Product Type & Application Table 38. Global Anti-Nausea and Vomiting Healthcare Device Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Anti-Nausea and Vomiting Healthcare Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Anti-Nausea and Vomiting Healthcare Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026) & (K Units) Table 43. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Region (2021-2026) Table 44. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026) & (US$ Million) Table 45. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Region (2021-2026) Table 46. Global Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032) & (K Units) Table 48. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Region (2027-2032) Table 49. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2027-2032) & (US$ Million) Table 50. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Region (2027-2032) Table 51. Global Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 54. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application (2021-2026) Table 55. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 56. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application (2021-2026) Table 57. Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2026) & (US$/Unit) Table 58. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 59. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application (2027-2032) Table 60. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (US$ Million) Table 61. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application (2027-2032) Table 62. Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2027-2032) & (US$/Unit) Table 63. North America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 64. North America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 66. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 70. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (US$ Million) Table 73. Blisslets Company Information Table 74. Blisslets Business Overview Table 75. Blisslets Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 77. Blisslets Recent Development Table 78. Dramamine(Prestige Consumer Healthcare) Company Information Table 79. Dramamine(Prestige Consumer Healthcare) Business Overview Table 80. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 82. Dramamine(Prestige Consumer Healthcare) Recent Development Table 83. EmeTerm (WAT Medical) Company Information Table 84. EmeTerm (WAT Medical) Business Overview Table 85. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 87. EmeTerm (WAT Medical) Recent Development Table 88. GRAVOL Company Information Table 89. GRAVOL Business Overview Table 90. GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 92. GRAVOL Recent Development Table 93. MotionCure (Sidis Labs) Company Information Table 94. MotionCure (Sidis Labs) Business Overview Table 95. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 97. MotionCure (Sidis Labs) Recent Development Table 98. NoMo Company Information Table 99. NoMo Business Overview Table 100. NoMo Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 102. NoMo Recent Development Table 103. Psi Bands Company Information Table 104. Psi Bands Business Overview Table 105. Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 107. Psi Bands Recent Development Table 108. Quease EASE (Soothing Scents) Company Information Table 109. Quease EASE (Soothing Scents) Business Overview Table 110. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 112. Quease EASE (Soothing Scents) Recent Development Table 113. Reliefband Company Information Table 114. Reliefband Business Overview Table 115. Reliefband Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 117. Reliefband Recent Development Table 118. Sea-Bands Company Information Table 119. Sea-Bands Business Overview Table 120. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 122. Sea-Bands Recent Development Table 123. Toulifly Company Information Table 124. Toulifly Business Overview Table 125. Toulifly Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 127. Toulifly Recent Development Table 128. Walgreens Company Information Table 129. Walgreens Business Overview Table 130. Walgreens Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 132. Walgreens Recent Development Table 133. North America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 135. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 136. North America Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Country (2027-2032) Table 138. North America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Anti-Nausea and Vomiting Healthcare Device Market Share by Country (2021-2026) Table 141. North America Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Anti-Nausea and Vomiting Healthcare Device Market Share Forecast by Country (2027-2032) Table 143. Europe Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 145. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 146. Europe Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Anti-Nausea and Vomiting Healthcare Device Market Share by Country (2021-2026) Table 151. Europe Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Anti-Nausea and Vomiting Healthcare Device Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Share by Country (2021-2026) Table 161. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Share Forecast by Country (2027-2032) Table 163. Latin America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 165. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 166. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Anti-Nausea and Vomiting Healthcare Device Market Share by Country (2021-2026) Table 171. Latin America Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Anti-Nausea and Vomiting Healthcare Device Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Share by Country (2021-2026) Table 181. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Anti-Nausea and Vomiting Healthcare Device Distributors List Table 186. Anti-Nausea and Vomiting Healthcare Device Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Anti-Nausea and Vomiting Healthcare Device Image Figure 2. Global Anti-Nausea and Vomiting Healthcare Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Nausea and Vomiting Healthcare Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Nausea and Vomiting Healthcare Device Sales (2021-2032) & (K Units) Figure 5. Inhaler Image Figure 6. Global Inhaler Sales YoY Growth (2021-2032) & (K Units) Figure 7. Wrist Band Image Figure 8. Global Wrist Band Sales YoY Growth (2021-2032) & (K Units) Figure 9. Food Image Figure 10. Global Food Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Anti-Nausea and Vomiting Healthcare Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Anti-Nausea and Vomiting Healthcare Device Market Share by Type 2025 VS 2032 Figure 15. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type in 2025 Figure 16. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type in 2025 Figure 17. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type in 2025 Figure 18. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type in 2025 Figure 21. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Anti-Nausea and Vomiting Healthcare Device Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. For Children Image Figure 28. Global For Children Sales YoY Growth (2021-2032) & (K Units) Figure 29. For Pregnant Image Figure 30. Global For Pregnant Sales YoY Growth (2021-2032) & (K Units) Figure 31. For other people with motion sickness Image Figure 32. Global For other people with motion sickness Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-Nausea and Vomiting Healthcare Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-Nausea and Vomiting Healthcare Device Market Share by Application 2025 VS 2032 Figure 35. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-Nausea and Vomiting Healthcare Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-Nausea and Vomiting Healthcare Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-Nausea and Vomiting Healthcare Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-Nausea and Vomiting Healthcare Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-Nausea and Vomiting Healthcare Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-Nausea and Vomiting Healthcare Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Nausea and Vomiting Healthcare Device Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-Nausea and Vomiting Healthcare Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaler
  • Wrist Band
  • Food
  • Others
Applications
  • For Children
  • For Pregnant
  • For other people with motion sickness
Companies covered
  • Blisslets
  • Dramamine(Prestige Consumer Healthcare)
  • EmeTerm (WAT Medical)
  • GRAVOL
  • MotionCure (Sidis Labs)
  • NoMo
  • Psi Bands
  • Quease EASE (Soothing Scents)
  • Reliefband
  • Sea-Bands
  • Toulifly
  • Walgreens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Nausea and Vomiting Healthcare Device Market by Type
  6. 1.3.1 Inhaler
  7. 1.3.2 Wrist Band
  8. 1.3.3 Food
  9. 1.3.4 Others
  10. 1.4 Global Anti-Nausea and Vomiting Healthcare Device Market Size by Type
  11. 1.4.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Anti-Nausea and Vomiting Healthcare Device Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Anti-Nausea and Vomiting Healthcare Device Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
  2. 2.2 Anti-Nausea and Vomiting Healthcare Device Industry Drivers
  3. 2.3 Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges
  4. 2.4 Anti-Nausea and Vomiting Healthcare Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Nausea and Vomiting Healthcare Device Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Nausea and Vomiting Healthcare Device Price (2021-2026)
  4. 3.4 Global Anti-Nausea and Vomiting Healthcare Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Nausea and Vomiting Healthcare Device Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Nausea and Vomiting Healthcare Device Company, Product Type & Application
  7. 3.7 Global Anti-Nausea and Vomiting Healthcare Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Nausea and Vomiting Healthcare Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Nausea and Vomiting Healthcare Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Nausea and Vomiting Healthcare Device Tier 1, Tier 2, and Tier 3
4 Anti-Nausea and Vomiting Healthcare Device Regional Status and Outlook
  1. 4.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Nausea and Vomiting Healthcare Device Historic Market Size by Region
  3. 4.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Nausea and Vomiting Healthcare Device Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Nausea and Vomiting Healthcare Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Nausea and Vomiting Healthcare Device by Application
  1. 5.1 Anti-Nausea and Vomiting Healthcare Device Market by Application
  2. 5.1.1 For Children
  3. 5.1.2 For Pregnant
  4. 5.1.3 For other people with motion sickness
  5. 5.2 Global Anti-Nausea and Vomiting Healthcare Device Market Size by Application
  6. 5.2.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti-Nausea and Vomiting Healthcare Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti-Nausea and Vomiting Healthcare Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Blisslets
  2. 6.1.1 Blisslets Company Information
  3. 6.1.2 Blisslets Business Overview
  4. 6.1.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  6. 6.1.5 Blisslets Recent Developments
  7. 6.2 Dramamine(Prestige Consumer Healthcare)
  8. 6.2.1 Dramamine(Prestige Consumer Healthcare) Company Information
  9. 6.2.2 Dramamine(Prestige Consumer Healthcare) Business Overview
  10. 6.2.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  12. 6.2.5 Dramamine(Prestige Consumer Healthcare) Recent Developments
  13. 6.3 EmeTerm (WAT Medical)
  14. 6.3.1 EmeTerm (WAT Medical) Company Information
  15. 6.3.2 EmeTerm (WAT Medical) Business Overview
  16. 6.3.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  18. 6.3.5 EmeTerm (WAT Medical) Recent Developments
  19. 6.4 GRAVOL
  20. 6.4.1 GRAVOL Company Information
  21. 6.4.2 GRAVOL Business Overview
  22. 6.4.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  24. 6.4.5 GRAVOL Recent Developments
  25. 6.5 MotionCure (Sidis Labs)
  26. 6.5.1 MotionCure (Sidis Labs) Company Information
  27. 6.5.2 MotionCure (Sidis Labs) Business Overview
  28. 6.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  30. 6.5.5 MotionCure (Sidis Labs) Recent Developments
  31. 6.6 NoMo
  32. 6.6.1 NoMo Company Information
  33. 6.6.2 NoMo Business Overview
  34. 6.6.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  36. 6.6.5 NoMo Recent Developments
  37. 6.7 Psi Bands
  38. 6.7.1 Psi Bands Company Information
  39. 6.7.2 Psi Bands Business Overview
  40. 6.7.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  42. 6.7.5 Psi Bands Recent Developments
  43. 6.8 Quease EASE (Soothing Scents)
  44. 6.8.1 Quease EASE (Soothing Scents) Company Information
  45. 6.8.2 Quease EASE (Soothing Scents) Business Overview
  46. 6.8.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  48. 6.8.5 Quease EASE (Soothing Scents) Recent Developments
  49. 6.9 Reliefband
  50. 6.9.1 Reliefband Company Information
  51. 6.9.2 Reliefband Business Overview
  52. 6.9.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  54. 6.9.5 Reliefband Recent Developments
  55. 6.10 Sea-Bands
  56. 6.10.1 Sea-Bands Company Information
  57. 6.10.2 Sea-Bands Business Overview
  58. 6.10.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  60. 6.10.5 Sea-Bands Recent Developments
  61. 6.11 Toulifly
  62. 6.11.1 Toulifly Company Information
  63. 6.11.2 Toulifly Business Overview
  64. 6.11.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  66. 6.11.5 Toulifly Recent Developments
  67. 6.12 Walgreens
  68. 6.12.1 Walgreens Company Information
  69. 6.12.2 Walgreens Business Overview
  70. 6.12.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  72. 6.12.5 Walgreens Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country
  2. 7.1.1 North America Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  6. 7.2.1 North America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country
  2. 8.1.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  6. 8.2.1 Europe Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Nausea and Vomiting Healthcare Device Sales by Country
  2. 10.1.1 South America Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  6. 10.2.1 South America Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Nausea and Vomiting Healthcare Device Value Chain Analysis
  2. 12.1.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Nausea and Vomiting Healthcare Device Production Mode & Process
  7. 12.2 Anti-Nausea and Vomiting Healthcare Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Nausea and Vomiting Healthcare Device Distributors
  10. 12.2.3 Anti-Nausea and Vomiting Healthcare Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst